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ABSTRACT 
Introduction 
Thyroid disorders both hypothyroidism and hyperthyroidism can affect the entire neuro 
axis resulting in various neurological manifestations. 
Aim of the study 
To identify the neurological manifestations of patients with thyroid disorders and to 
emphasize the need for thyroid screening in patients with  neurological symptoms 
Materials and methods 
100 patients with thyroid disorders who attended Endocrinology and Neurological 
services at Rajiv Gandhi Govt. General hospital, Chennai, between December 2012 and 
February 2014 were included for the study. Patients with diabetes, renal failure, liver 
disorders and other chronic illness were excluded from the study. All patients underwent 
neurological examination and thyroid function tests. Selective investigations like neuro 
imaging, electroencephalogram, nerve conduction studies and electromyography were 
done according to the patient symptoms. 
Results and Discussion 
Total number of patients were 100 of which 50 patients were Hypothyroid and 50 
patients were Hyperthyroid. The neurological manifestations observed in hypothyroidism 
were headache 12%, Sleep disorders 8%, cognitive decline 4%, Hashimoto’s 
encephalopathy 4%, cerebellar involvement 2%, myeloneuropathy 2%, carpal tunnel 
syndrome 10%, peripheral neuropathy 10% and myopathy 2%. The neurological 
manifestations observed in hyperthyroidism were tremor 74%, headache 16%, Sleep 
disorders 8%,  peripheral neuropathy 4%, myopathy 4% and thyrotoxic periodic paralysis 
2%. Since it is observed from the study that thyroid disease can affect the entire neuro 
axis emphasizing the need for thyroid function testing. It important also important to 
screen for immunology testing like thyroid peroxidase antibody in selective cases  and if 
found may need to treat with immunosuppression. On comparing  neurological features 
associated with hypo and hyperthyroidism, the association is significantly high in 
hypothyroidism  
 
Conclusion: 
 Thyroid disorders can affect the entire neuro axis and may present with neurological 
manifestations without specific symptoms and signs of thyroid dysfunction. This 
emphasis the need for thyroid function testing in patients presenting with neurological 
symptoms even without classical thyroid symptoms. 
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INTRODUCTION 
 
 The thyroid gland is an important endocrine gland which has actions on 
many systems of the body. It is located on each side of and anterior to the 
trachea. It is one of the largest of the endocrine glands. It weighs 15 to 20 
grams in adults. The two major hormones secreted by thyroid gland are 
thyroxine and tri iodothyronine commonly called  T4 and T3. 
 
 93% of hormones secreted by the thyroid gland is T4 and only 7% is 
T3.Thyroxine is believed to be a prohormone and a reservoir for the most 
active and main thyroid hormone T3. T4  is converted as required in the tissues 
by iodothyronine deiodinase to the more potent T3.  
 
 There are two thyroid hormone receptor genes TRα and TRβ. Thyroid 
hormone exhibits its action by combining with these receptors and is mainly 
mediated by Tri siodothyronine(T3). In general, energy metabolism are 
regulated by TRα and feedback regulation are functions of TRβ. T3 receptor  
are located predominantly on neurons
1,2
. T3 receptors in  neurons  mediate the 
effects of the hormone  for   neuronal cell migration and differentiation. It is 
well known oligodendrocytes are the principle glia of central  nervous systems 
and  schwann cells are the principle glia of peripheral nervous systems. 
Thyroid  hormone is required for oligodendrocyte differentiation and 
myelination
3.
  Schwann cells have been reported to express  T3 receptors which 
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shows the  necessity of thyroid hormones for its normal functioning 
4
. Hence it 
is well understood both central nervous system and peripheral nervous are 
depended on thyroid hormones for normal functioning.  
Under action of thyroid hormones affecting nervous system 
 Thyroid hormones is necessary for the maturation of specific neurons 
and hence absence of these hormones during the period of active brain 
development  leads to irreversible damage to brain causing  mental 
retardation
5
. 
 Thyroid hormone deficiency slows metabolism, resulting in low energy 
expenditure, oxygen consumption, and utilization of substrates. The basal 
metabolic rate is reduced. Cold intolerance in hypothyroid patients is due 
to reduced  thermogenesis. 
 
 In  proportion to the drop in metabolic rate of the rest of the body the 
cerebral blood flow, oxygen consumption, and glucose consumption is 
reduced
6
. In addition to decrease in cerebral glucose metabolism  there is also 
decrease in cerebral blood flow  causing  global decrease in brain activity in 
severe hypothyroidism
7
 . 
 
 Thyroid deficiency causes myopathy due to disturbances in the 
mitochondrial oxidative pathway and abnormal glycogenolysis . There is 
change in more active fast twitching type II muscle fiber to slow twitching    
type I muscle fiber leading to delayed relaxation phase of ankle jerk.  
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Over action of thyroid hormones affecting nervous system 
 On the other hand increase in thyroid hormones in hyperthyroidism 
causes over activity of target organs and results in neurological symptoms. 
 
 Hyperthyroidism causes increase in sodium-potassium adenosine 
triphosphatase (Na/K-ATPase) pump activity resulting in massive shift of 
potassium from the extracellular into the intracellular compartment and this 
happens mostly in muscles leading to weakness and the condition called 
thyrotoxic periodic paralysis. 
 
 Hyperthyroidism is associated with myopathy. The pathogenesis of 
muscle dysfunction in thyrotoxicosis  is due the to direct effect of elevated 
level of thyroid hormones.  Thyroid hormones increase lysosomal activity 
causing proteolysis of muscle fibres. Thyroxine  induces disturbance of 
oxidative phosphorylation which also leads to muscle dysfunction   
Normal thyroid action but immune mediated disorder affecting nervous 
system 
 Hashimoto‟s encephalopathy is an autoimmune disorder. In this 
condition thyroid function may be hypo, hyper or euthyroid but but thyroid  
peroxidase antibody levels are elevated. The response to steroid and other 
immunomodulatory therapies suggests an autoimmune disorder.  
  
9 
 
AIM OF THE STUDY 
 
 To assess the neurological manifestations of patients with thyroid 
disorders. 
 
 To study the prevalence of various neurological manifestations in 
hypo/hyperthyroidism. 
 
 To emphasize the need for thyroid screening in patients with  
neurological symptoms. 
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REVIEW OF LITERATURE 
 
PHYSIOLOGY OF THYROID HORMONES 
 Thyroxin T4 and triodothyronine T3 are the principle hormones 
produced by the thyroid gland.  Ingested iodine is absorbed from the gut gets 
converted to iodide and bound to serum albumin and transported through the 
blood.  Thyroid gland actively extracts iodide from the circulation by iodide 
trapping mediated by sodium iodide symporter (NIS).  The NIS mediated 
iodide transport is highly regulated, i.e., low iodide levels increases NIS and 
increases iodide uptake and vice versa. The trapped iodide is oxidized to 
iodine and this reactive iodine atom is added to selected thyrosyl residues in 
thyroglobulin (Tg) by the process called organification forming iodothyrosin. 
This iodothyrosin forms T4 or T3 by coupling. The oxidation, organification 
and coupling reactions are catalised by thyroid peroxidase. Thyroid hormones 
thus produced are bound to thyroglobulin and secreted in blood where it binds 
to thyroid binding globulin (TBG), Transthyritin and albumin and remaining 
as free hormones which is active. 
 
CONTROL OF THYROID HORMONES 
Thyroid stimulating hormone (TSH) controls the secretion of T3 and T4. 
It is secreted in a pulsatile manner by pituitary gland with peak secretion in the 
night.  TSH secretion is stimulated by thyroid releasing hormone (TRH) which 
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is secreted from hypothalamus. Both TRH and TSH release are under negative 
feedback of free T3 and T4. 
 
 
  
ACTIONS OF THYROID HORMONES 
Thyroid hormones acts by binding to the nuclear thyroid hormone 
receptors TRα1, TRα2 and TRβ1, TRβ2. All most all tissues express TRα1, 
TRα2 and TRβ. But TRβ is high in pituitary, hypothalamus and is responsible 
for feedback control of thyroid axis.  FT3 has 10 to 15 times greater affinity 
than FT4 to TRα and TRβ which explains the increased potency of free T3.  
The receptor sites are mainly occupied by T3.    
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Mechanism of action of Thyroid hormone at the receptor level in various 
systems of the body is represented in this figure. 
 
 Thyroid hormone dysfunction can affect multiple systems in the body 
and can present as emergency to the neurologist like hypokalemic periodic 
paralysis, myxedema coma or to the cardiologist like pericardial effusion, 
cardiac arrhythmia. 
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Based on the following algorithm thyroid disorders are classified as 
follows  
 
 
In patients with immune mediated disorders thyroid function tests may be 
normal it is important to measure Anti Thyroid specific antibodies  
 
In general hormone excess (hyperthyroidism) can present with some of the 
following symptoms and signs 
 
 Thyroid enlargement (depending on cause)   
 Pretibial myxedema (in patients with Graves‟ disease) 
 exophthalmos, changes in visual acuity, diplopia 
 Palpitations and tachycardia 
 Heat intolerance or increased sweating 
 Weight loss  
 Alterations in appetite 
 Frequent bowel movements or diarrhea 
 Exertional intolerance and dyspnea 
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 Impaired fertility  
 Nervousness and irritability 
 Tremor 
 Fatigue and muscle weakness 
 Sudden paralysis 
 Mental disturbances 
 Sleep disturbances (including insomnia) 
 
Low thyroid hormone levels(hypothyroidism) can present with some of the 
following symptoms an signs 
 Goiter 
 Fatigue 
 Weight gain  
 Dry skin  
 Yellow skin 
 cold intolerance 
 Coarseness or loss of hair 
 Constipation 
 Irregular or heavy menses  
  Infertility 
 Bradycardia  
 hypothermia 
 Myxedema (fluid infiltration of tissue) 
 Decreased concentration 
 Memory and mental impairment 
  Depression 
 Ataxia  
 Hoarseness of voice  
 Muscle weakness 
 Reflex delay causing delayed relaxation phase of ankle jerk 
 
Link between thyroid hormones and neurology 
 The thyroid hormone receptor is a type of nuclear receptor and it is more 
abundant in the brain. Hence alteration in thyroid hormones leads to either 
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under or over activity of these receptors causing central nervous system 
dysfunction. The peripheral nervous system can also get affected because 
thyroid hormone alterations causing metabolic abnormalities of the Schwann 
cell. Muscle involvement can occur because thyroid dysfunction causes to 
metabolic disturbances in mitochondrial oxidative metabolism. 
 
 In addition to direct effect of thyroid hormone causing neurological 
dysfunction, immune mediated mechanisms can also operate as in 
Hashimoto‟s encephalopathy in which condition thyroid hormone levels may 
be normal. 
 
Neurological manifestations of Hypothyroidism 
 The most common neurological symptoms of hypothyroidism are 
Impaired memory, slowed mental processing, depression, psychotic behavior, 
nerve entrapment syndromes, peripheral neuropathy, myasthenia gravis, sleep 
disturbances and  ataxia.  
 
Hypothyroidism and cognition 
Hypothyroidism in perinatal period 
                  Thyroid hormones is necessary for the maturation of specific 
neurons and hence absence of these hormones during the period of active 
neurogenesis leads to irreversible damage to brain causing mental retardation. 
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                  Brain-derived neurotrophic factor (BDNF) is a neurotrophin. It is 
most essential for the development of central nervous system and thus its 
function. Hence  lack of thyroid hormones during early neonatal period causes 
reductions in mRNA and protein expression of BDNF in specific brain 
regions
8
.  This results in impairment of normal brain development. 
 
 The target site of action of thyroid hormones are the thyroid hormone 
receptors. The receptors for thyroid hormone T3 are localized in nuclei of glial 
cells. It is well known that the T4 has to be converted to T3 to exhibit the 
receptor mediated actions. The enzyme deiodinase type II, is mainly 
responsible for converting inactive T4 to active form T3 is also present in glial 
and neural cells
6
. Hence perinatal hypothyroidism results in under activations 
of these receptors resulting in permanent alterations of hippocampal synaptic 
functions leading to  cognitive impairment which is moderate to severe. 
 
Hypothyroidism in adult  
 It is well known that defective thyroid hormone during neonatal period 
affect active neurogenesis resulting in mental retardation. Even after 
neurogenesis,  hypothyroidism  in adults can cause impairment in learning 
abilities and memory impairment. 
 
 The adult hippocampal progenitors exhibit enhanced proliferation, 
survival and glial differentiation in response to thyroid hormone as 
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demonstrated in vitro studies in adult rat brain
9
. These results support a role for 
thyroid hormone in the regulation of adult hippocampal neurogenesis and raise 
the possibility that altered neurogenesis may contribute to the cognitive and 
behavioral deficits associated with adult-onset hypothyroidism 
 
 Thyroid hormones have been reported to modulate astrocyte 
morphology, differentiation, and proliferation and to regulate extracellular 
matrix organization and synthesis
10
. Thyroid  hormones regulate the vimentin-
GFAP (glial fibrillary acidic protein) switch, a hallmark of astrocyte 
differentiation, in the basal forebrain and hippocampus
10
. 
 
 After thyroxine replacement, the central nervous system function 
usually returns to normal if the hypothyroid state was not more than 5 months 
in duration. But, when hypothyroid state persisted more than  7 months , there 
would be an incomplete recovery . This study brought out the concept of 
„therapeutic window‟ in reversing the central nervous dysfunction caused by 
hypothyroidism in adult rats
11
. 
 
 Insufficiency of thyroid hormones in the adulthood causes impairment 
of cognitive functions which is milder than during neonatal or infancy were the 
brain development is more. In a study that investigated whether adult-onset 
hypothyroidism would alter synaptic functions in the dorsal hippocampo-
medial prefrontal cortex (mPFC) pathway, a neural pathway important for 
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learning and memory, the results suggested that alterations in synaptic 
plasticity of the dorsal hippocampo-mPFC pathway might contribute to 
understanding basic mechanisms underlying learning and memory deficits 
associated with adult-onset hypothyroidism
11
. 
 
Association of Headache with Hypothyroidism 
 Many types of headaches and migraine often found to be coexisting with 
hypothyroidism.  The exact nature of headache in hypothyroidism is not 
known.  It is often found a pre existing headache like migraine tend to be 
aggravated by the development of hypothyroidism and these headaches may 
show refractiveness to treatment.  Hence some authors recommend to check 
thyroid hormones as a routine in evaluating headache.  More importantly it is 
wise to check thyroid hormone levels in patients who has primary headache 
which is  refractory  to treatment. 
 
Hypothyroidism and depression  
 Hypothyroidism can manifest with psychiatric symptoms like 
depression, mental retardation and even psychosis.  Treatment of psychiatric 
symptoms alone without correction of the underlying primary cause often 
results in failure of treatment. Hence it is essential to look for thyroid function 
abnormalities in patient with psychiatric symptoms.  Bipolar disorder with 
rapid cycling form occurs especially in women with hypothyroidism.  It has 
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been observed certain mood abnormalities are present even in patients with 
subclinical hypothyroidism.  
 
Sleep disorders in hypothyroidism   
 Hypothyroidism can cause abnormal sleep architecture, abnormal 
ventilator drive and sleep apnea
12
. The sleep apnea may be due to central 
causes, obstructive cause or due to both. The hypothyroid associated 
symptoms lethargy, somnolence and intellectual deterioration may be 
attributed to hypothyroid associated sleep problems in addition to direct 
hormonal effect. Myxedema is a reversible cause of sleep apnea and diagnostic 
work up for thyroid function should considered in sleep apnea. 
 
Hashimoto’s encephalopathy 
 Hashimoto's encephalopathy is an immune mediated  disorder causing 
autoimmune encephalopathy  characterised by high titers of anti-thyroid 
peroxidase antibodies
15,16
. It has been reported in all age groups pediatric, adult 
and elderly and is more common in females. It is characterized clinically by 
altered conscious state, rapid cognitive decline, myoclonus, stroke like 
episodes and neuropsychiatric symptoms like psychosis, hallucinations, and 
abulia
14
. The course of illness is relapsing and remitting. Treatment is with 
intravenous steroids followed by oral steroids
13
. Other immunomodulation 
therapy like IVIg and plasma exchange are also effective. Relapse may occur 
if this treatment is ceased abruptly. The treatment of steroids is continued for 
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months and modified according to the clinical response to treatment and 
monitoring the TPO antibody levels. Pathological findings can suggest an 
inflammatory process, but evidence of severe vasculitis are often absent.  It is 
considered to be nonvasculitic autoimmune inflammatory 
meningoencephalopathies
17
. Thyroid  function  tests is usually normal. It is an 
important to consider in differential diagnosis of rapidly progressive dementia 
because of the reversible nature of illness with treatment. 
 
Cerebellum and hypothyroidism  
                 Hypothyroidism may cause slowly progressive ataxia secondary to 
cerebellar degeneration. There are two separate mechanisms postulated  in 
cerebellar dysfunction in patients with thyroid disorders. It is directly due the 
deficiency of thyroid hormones or indirectly due to autoimmune mediated 
mechanism. In thyroid hormone deficient status cerebellar dysfunction  could 
be reversed by thyroid replacement
18
. The possible mechanism could be under 
activity of thyroid hormone suppresses the mitochondrial function which is 
mostly need for purkinje fibers. In patient with autoimmune mediated 
cerebellar degeneration steroid remains the treatment of choice. Degenerative 
changes are seen in cerebellum, particularly in  anterosuperior portion of the 
vermis, together with atrophy of ventral portion of the pons, transverse pontine 
fibres, and middle and superior peduncles
19
. The imaging of these patients may 
show midline and cerebellar hemisphere atrophy and even brain stem.                 
21 
 
 
              Cerebellar development during the infancy is characterise by 
proliferation of the external granular layer and migration of the granule cell in 
the molecular layer.  These functions are reduced in thyroid hormone 
deficiencies which are mainly mediated by TRα and TRβ receptors.  This is 
one of the best studied mechanism of receptor mediated action of thyroid 
hormone.  The target receptor is predominantly TRβ in cerebellum 
ontogenesis.  In one study they have found that TRβ mutant mice having 
severe deficit in proliferation of granule cells, arborization of purkinje cells 
and migration defects.  Hence the target inactivation of TRβ could lead to 
impaired lamination and foliation leading to cerebellar atrophy inspite of 
normal thyroid hormone levels.        
 
Hypothyroid effects on peripheral nervous system 
 Hypothyroidism can cause peripheral neuropathy . In comparison to 
central nervous system, the peripheral nervous system is less affected in 
hypothyroidism. The severity of the clinical picture of the neuropathy was 
more related to the duration of the disease than to the severity of the thyroid 
hormone deficiency. Both neurophysiological and pathological findings shows 
primary axonal  sensorimotor polyneuropathy
23
.  Study of cases of peripheral 
neuropathy   morphologically and neurophysiologically  suggest that metabolic 
alterations caused by endocrine disorders are responsible for the peripheral 
neuropathy
20
. They suggested that these metabolic alterations affect essentially 
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the Schwann cell inducing a segmental demyelination. Recent observations 
have not confirmed the previous ones. Some investigators
 
found 
morphological evidence of primary axonal degeneration. In teased fibres they 
demonstrated arrays of myelinated ovoids in most fibres; with electron 
microscopy they found axonal shrinkage, disintegration of neurotubules and 
neurofilaments leading to axonal break down
21,22
. There is segmental 
demyelination secondary to axonal degeneration. Painful neuropathy due to 
small fiber involvement can also occur in hypothyroidism
24
. 
 
 Pathophysiology may be due to deposition of  mucopolysaccharide or 
the myxedematous tissue which leads to compression over the peripheral 
nerves and thereby results in swelling and degeneration of them
25
.It has also 
been suggested that the thyroid hormones stimulate the mitochondrial 
respiratory activity to produce energy in the form of ATP during aerobiosis 
under normal physiological condition. Hormones also increase the ATPase 
activity and consequently Na+/K+ pump activity in this group of patients. 
Therefore, deficiency of ATP and reduced ATPase and decreased Na+/K+ 
pump activity cause subsequent alteration of pump dependent axonal transport 
and thereby may lead to peripheral neuropathy. Decrease glycogen degradation 
may also leads to energy deficit in hypothyroidism
26
. 
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Entrapment neuropathy 
Carpal Tunnel Syndrome (CTS) 
 The most common entrapment neuropathy associated with 
hypothyroidism is carpal tunnel syndrome. Carpal tunnel is the space between 
carpal bones and transverse carpal ligament. The median nerve passes through 
this space along with nine flexor tendons. The median nerve is vulnerable to 
compression where in conditions like edema, boney abnormalities, soft tissue 
swellings which increases the pressure in the carpal tunnel. It can occur in 
other disorders which reduce the space of carpal tunnel like rheumatoid 
arthritis, thickening of synovium, acromegaly, pregnancy etc. 
 
 The clinical features of CTS are parasthesias over the hand which may 
also extend proximally to elbow and to even shoulders.  There is sensory loss 
over the first three digits and radial half the fourth digit.  There is sparing of 
sensation over the thenar eminent because the palmar cutaneous nerve which 
supply this area arises three centimeter proximal to carpal tunnel and travels 
outside the carpal tunnel.  There can be vasomotor changes which causes 
swelling, cold and shinny skin.  Wasting of thenar muscle occur in advanced 
stages.   
The electro diagnostic criteria for CTS 
 Distal median motor latency >4.4ms 
24 
 
 Difference between distal motor latency of median and ulnar nerve 
>1.1ms 
 Difference between distal sensory latency of median and ulnar nerve 
>0.2ms 
 Difference between median and ulnar sensory latency on stimulating 
fourth digit and recording from wrist at equal distance >0.2ms 
 Difference between median and radial sensory latency on stimulating 
thumb and recording from wrist at equal distance >0.4ms 
 Palm wrist conduction:difference between median and ulnar sensory 
latency across 8cm > 0.4ms 
 Inching technique: latency jump >0.2ms/cm 
 Comparison of lumbrical (median nerve) and interosseous (ulnar nerve) 
latencies more than 0.6ms  
 
Tarsal Tunnel Syndrome 
 Similar to CTS posterior tibial nerve can be compressed when travelling 
under the flexor retinaculum in the tarsal tunnel resulting in the syndrome 
called Tarsal Tunnel Syndrome.  These patients have burning sensation, 
tingling and numbness of the feet aggravated by standing and walking for long 
distance.  There may be atrophy of abductor hallucis.  In electro physiological 
testing,  the distal motor latency of the tibial nerve is prolonged. Measurement 
of sensory potential in the medial plantar nerve increases the diagnostic yield.  
25 
 
However because of myxedema associated with hypothyroidism it is difficult 
to test this sensory nerve.  Compare to CTS in hypothyroidism Tarsal Tunnel 
Syndrome is rare.   
 
Hypothyroid myopathy 
 The muscular symptoms are common in hypothyroid and may range 
from 30-80%. The symptoms are myalgia, muscle cramps, muscle stiffness 
and weakness. Muscular hypertrophy  reported in <10% of patients. This is a 
pseudo hypertrophy, the possible mechanisms being  increase in connective 
tissues, increase in size and number of the muscle fibres and accumulation of 
glycosaminoglycans
27,28
.The muscle weakness associated with muscle 
hypertrophy in adults is called Hoffman‟s syndrome and in childhood is called 
Kocher-Debre-Semelaigne syndrome. Calf muscle hypertrophy accompanies 
wide variety of diseases like Duchenne, Becker‟s muscular dystrophy and limb 
girdle muscular dystrophy. 
 
 On examination the deep tendon reflexes are delayed. This is   
pseudomyotonic reflexes where the pathophysiology is due decrease in 
Calcium ATPase activity secondary to under action thyroid hormones 
affecting  fast twitching type-II of muscle fibres  producing delayed relaxation 
of the reflex
30
. There may be myoedema in which there is mounding of muscle 
after light percussion
29,31
. 
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  The pathogenesis of hypothyroid myopathy is probably related 
deficiency of thyroid hormones causing abnormal glycogenolysis, decreased 
protein turn over  and  defective mitochondrial oxidative metabolism
22
. There 
is a shift of fast twitching muscle fibres to slow twitching muscle fibres. 
Muscle biopsies shows non specific changes with evidence of  type II fibre 
atrophy
23
.  
 
Change in muscle fiber type due to under action of thyroid hormones  
 
Slow twitching Type – I fiber and fast twitching Type – II fibre in muscle 
                                                                 Under action of thyroid 
                                                                 hormones in hypothyroidism 
 
                      Predominant slow twitching Type – I fibres 
              The serum creatine kinase(CK) is elevated 10 to 100 times. The serum 
CK does not correlate  with the severity of weakness. Severity of muscle 
weakness is in proportion to the duration and degree of thyroid hormone 
deficiency. Thyroid hormone replacement therapy causes improvement in 
muscle power and reduction in CK level. 
                               
Myxedema coma 
 In patients with  long-standing untreated hypothyroidism myxedema 
coma can occur. It often precipitated by an acute event . 80% cases are females 
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and occurs almost exclusively in elderly patients  and occur during the month 
of winter. 
 
Precipitating Factors: 
 Infection like urinary tract infection and pneumonia 
 Acute stress like myocardial infarction, stroke, congestive cardiac 
failure, surgery and trauma 
 Drugs (Noncompliance with thyroid hormone replacement therapy, 
sedatives, tranquilizers, anesthetics, amiodarone, beta-blockers, lithium) 
 Gastro intestinal bleeding 
 Winter season 
 Hypoglycemia 
 
Clinical Manifestations: 
 The three cardinal Features of myxedema coma are altered sensorium, 
defective thermoregulation and a precipitating event or illness 
Neurological manifestations: 
 It causes deterioration of mental status which may be range subtle to 
very severe form of coma. The subtle manifestations include apathy, cognitive 
impairment to more severe form like confusion, psychosis and coma. It is ideal 
to do mental status examination in a  patients in suspected myxedema coma 
28 
 
since initially patient will have mild cognitive decline and only a few progress 
to coma. 
 
Other signs and symptoms: 
 The patient's temperature is usually less than 35.5°C (95.9°F). Many 
patients euthermic due to superimposed infection. 
 Skin and Soft Tissue – Generalized and Periorbital edema, skin is cool 
and dry 
 Cardiovascular manifestations like Bradycardia and Hypotension 
 Respiratory system involvement causing hypoventilation with 
respiratory acidosis. This manifestation is mainly centrally mediated, 
but may be complicated by diaphragmatic muscle weakness induced by 
hypothyroidism. 
 Gastrointestinal manifestations like constipation, abdominal 
distension/pain, and paralytic ileus 
 
Diagnosis: 
  Diagnosis is based on exclusion of other causes of altered mental status  
and grossly decreased to undetectable  levels of Free T4 (and T3).  
 
 TSH levels are grossly elevated, but it may be  low in the setting of 
hypothalamic-pituitary disease  
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 Blood investigation may reveal hematological abnormalities like 
anemia, leucopenia, metabolic abnormalities like hyponatremia, 
hypoglycemia, hypoxemia and elevated CK or LDH levels secondary to 
hypothyroid induced muscle altered membrane permeability. 
 
Treatment 
 Treatment should be initiated without waiting for laboratory 
confirmation of hypothyroidism 
Supportive Measures 
 Oxygen  and  mechanical ventilation if hypoventilation 
 IV fluids for hypotension (caution in using  pressors since this may 
exacerbate cardiac arrhythmias with IV thyroid replacement therapy) 
 Warming  room temperature and covering patients with blankets for 
hypothermia ( avoid rapid rewarming as it is associated with peripheral 
dilatation and may precipitate hypotension/CV collapse) 
 Hypoglycemia managed with IV dextrose infusion 
 Hyponatremia may be treated with saline, fluid restriction +/- loop 
diuretics 
 Treat precipitating factors 
Thyroid Replacement 
 Because GI absorption is compromised, intravenous therapy is 
mandatory. While the necessity of intravenous thyroid hormone replacement is 
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apparent, some controversy exists regarding the use and dosages of 
levothyroxine (T4) and liothyronine (T3). Because of the relatively small 
number of patients with myxedema coma, controlled studies comparing 
various dosages of T4 and T3 are lacking. Because T3 is more biologically 
active than T4, and the conversion of T4 to T3 is suppressed in myxedema 
coma, some have advocated T3 replacement. However, parental T3 is not only 
expensive and difficult to obtain, it may also contribute to increased mortality 
as it causes cardiac arrhythmia. 
 
 An intravenous loading dose of 500-800 mcg of levothyroxine is 
followed by a daily intravenous dose of 50-100 mcg; the daily dose is 
administered until the patient is able to take medication by mouth. Some 
authorities advocate the use of additional intravenous T3, at 10-20 mcg every 
8-12 hours, especially in young patients with low cardiovascular risk. 
Steroids  
 It is ideal to administer steroids considering the possibility of secondary 
hypothyroidism as in hypopituitarism where there is associated adrenal 
insufficiency and the possibility of adrenal crisis. Hydrocortisone 100mg sixth 
hourly is the treatment of choice. Cortisol level should be drawn prior to 
therapy, and if not depressed, the hydrocortisone can be discontinued without 
tapering. 
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Neurological manifestations of Hyperthyroidism 
 Hyperthyroidism can cause neurological manifestations like insomnia, 
seizures, encephalopathy, neuropsychiatric  manifestations, thyroid associated 
ophthalmopathy,  movement disorders like tremors, choreoathetosis,  
myopathy,  hypokalemic periodic paralysis and myasthenia gravis. 
 
Sleep disturbances in hyperthyroidism 
 Hyperthyroidism is associated with sleep disorders, the most common 
being insomnia. They have difficulty in initiating sleep, difficulty maintaining 
sleep, or waking up too early and probably related to the hyper metabolic state 
and anxiousness
32,33
. Due to the poor sleep during night they can have day time 
impairment like fatigue, concentration or memory impairment, poor school 
performance, mood disturbance,  irritability and daytime sleepiness.  
 
Association of Headache with Hyperthyroidism 
 Many types of headaches including  migraine often found to be 
coexisting with hyperthyroidism.  The exact nature of headache in 
hyperthyroidism is not known.  It is often found a pre existing headache like  
migraine tend to be aggravated by the development of hyperthyroidism. 
Factors associated with hyperthyroidism like fatigue, perspiration, anxiety, 
decreased sleep, rapid beating of heart and changes in menstrual cycle 
aggravate the pre existing headache.  Thyroid problem are more prevalent in 
women.  It has been suggested the estrogen levels are high in patients suffering 
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from hyperthyroidism affecting the hormonal balance, thus causing menstrual 
irregularity.  This increased estrogen level could play a role in the causation of 
headache in women.  Hence it is ideal to check patients with refractory 
primary headache for thyroid abnormalities.   
 
Psychiatric Manifestations of Hyperthyroidism 
 Hyperthyroidism can cause various psychiatric manifestations like 
depression, anxiety
34
, panic disorders
36
, psychosis
37
 and  bipolar disorders
39
. 
Treatment of hyperthyroidism results in improvement of symptoms in parallel 
to the improvement in hyperthyroid symptoms
38
.  But some patients need anti 
psychiatric drugs due to the persistence of psychiatric symptoms remaining 
after ameliorations of hyperthyroidism.    
 
Encephalopathy in hyperthyroidism 
 These clinical manifestations are seen in Hashimoto‟s encephalopathy 
which is due to autoimmune etiology where the patient may be hyper or hypo 
or euthyroid. The possible mechanism of nonvasculitic autoimmune 
inflammatory meningoencephalopathies is attributed  as already mentioned.  
 
Thyroid-associated ophthalmopathy (TAO).  
 It is an inflammatory disease  involving the orbital tissues
39
. The 
inflammation is cytokine mediated and this results in proliferation of 
fibroblast, increased deposition of extracellular matrix, proliferation of 
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adipocytes. There is edema, inflammation and fibrosis causing of restriction of 
extra ocular muscle movement.  
 There are 3 main subtypes of TAO: congestive ophthalmopathy, ocular 
myopathy, and a mixed form.  
Congestive ophthalmopathy  
           It is characterized by inflammation of the orbital connective tissue, with 
relative sparing of the extra ocular muscles and manifests clinically with eye 
swelling, conjunctival injection, chemosis, watery or gritty eyes, and 
exophthalmos.  
Ocular myopathy 
           It is characterized by inflammation and swelling of the extraocular 
muscles, and manifests as ophthalmoparesis, diplopia, and occasionally painful 
eye movements. 
Mixed congestive and myopathic ophthalmopathy          
         It is the most common  presentation. 
Thyroid-Associated Ophthalmopathy Grading System 
       Grade   Clinical findings 
 0  - No symptoms or signs 
 1  - Only signs-Lid lag, stare, upper eyelid retraction 
 2  - Soft tissue involvement-Eyelid or conjunctival swelling 
 3  - Proptosis 
 4  - Extraocular muscle involvement 
 5  - Corneal ulceration 
 6  - Sight loss- Compressive optic neuropathy 
 
Mnemonic : “NO SPECS” 
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Neuromuscular junction disorders  
 Myasthenia gravis may be seen in a proportion of patients with 
hyperthyroidism(Graves disease)
41,42
. Patients with myasthenia gravis have an 
increased incidence of thyroid disorders; and 5 to 10% of myasthenic patients 
are hyperthyroid
40,43
. The coexistence of the two conditions is probably due to 
the underlying genetic predisposition to autoimmune disease 
 
Hyperthyroid myopathy 
 Myopathy associated with hyperthyroidism can be acute and chronic 
thyrotoxic myopathy.  
 
Acute thyrotoxic myopathy 
 Acute thyrotoxic myopathy appears within days of onset of 
thyrotoxicosis. This is due to the rapid degradation of the muscle fibers.  It is 
usually associated with severe muscle cramps and muscle pain.  It can also 
cause weakness of respiratory muscle resulting in respiratory failure.  Rapid 
course with rhabdomyolysis,  myoglobinuria, and renal failure may occur with 
severe thyrotoxicosis  
Chronic thyrotoxic myopathy 
 Muscle symptoms usually appear 6 months after the onset of 
thyrotoxicosis. Myalgias, fatigue, and poor exercise tolerance are common 
presenting symptoms.  It is a slowly progressive illness which preferentially 
affects pelvic girdle and thigh muscles.  Most importantly despite the muscle 
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weakness and wasting, serum creatine kinase remains normal in contrast to 
hypothyroid induced myopathy.  
 
 In contrast to hypothyroid myopathy where there is type I slow 
twitching fibers predominance, in hyperthyroid myopathy there is 
predominance of fast twitching type II fibers on histopathological examination.  
The pathogenesis of muscle disfunction is due the increased thyroid hormone 
levels causing disturbances in oxidative phosphorylation
44
.  The thyroid 
hormone also increases the lysosomal activity leading to distruction of muscle 
fibers
45
.  There is muscle atrophy due to the increased protein catabolism.     
 
Change in muscle fibre type due to over action of thyroid hormones
26
  
 
Slow twitching Type – I fibre and fast twitching Type – II fibre in muscle 
                                                                 Overaction of thyroid 
                                                                 hormones in hyperthyroidism 
 
                      Predominant fast twitching Type – II fibres 
 
Thyrotoxic Periodic Paralysis (TPP)  
 TPP is an alarming and potentially lethal complication of 
hyperthyroidism characterized by muscle paralysis and hypokalemia due to a 
massive intracellular shift of potassium
46
. This condition mainly affects male 
patients of Asian descent. Many affected patients do not have obvious 
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symptoms and signs of hyperthyroidism. Hence it is necessary to check TFT in 
patients presenting with TPP even without signs and symptoms of 
hyperthyroidism. 
 
Pathogenesis  of TPP 
 Hypokalemia in TPP is the consequence of a rapid and massive shift of 
potassium from the extracellular into the intracellular compartment,mainly into 
the muscles. This is believed to be related to increased sodium-potassium 
adenosine triphosphatase (Na/K-ATPase) pump activity. Overall, the data 
revealed an increased number as well as activity of the Na/K-ATPase pump in 
patients with thyrotoxicosis. Patients with TPP had significantly higher pump 
activity than thyrotoxic patients without TPP. When thyrotoxicosis was 
controlled, Na/K-ATPase activity returned to a level similar to that of healthy 
controls.Thyroid hormones can increase Na/K-ATPase activity in skeletal 
muscle, liver, and kidney to induce an influx of potassium into the intracellular 
space . Among the various Na/K-ATPase subunits, the α1-, α2-, β1-, β2-, and 
β4-subunits are expressed in  skeletal muscles .Thyroid hormone-responsive 
elements are present in the upstream region of these five genes, and thyroid 
hormones has been shown to increase Na/K-ATPase activity via both 
transcriptional and posttranscriptional mechanisms. Apart from direct 
stimulation by thyroid hormones, catecholamine can also increase 
Na/KATPase activity in skeletal muscle .The enhanced β-adrenergic response 
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in thyrotoxicosis further increases Na/K-ATPase activity and may explain why 
nonselective β-adrenergic blockers can abort or prevent paralytic attacks. 
 
 In addition to an increased adrenergic response, patients with TPP have 
an exaggerated insulin response during oral glucose challenge, compared with 
thyrotoxic patients without TPP. Insulin-response sequences are present in the 
upstream region of Na/KATPase genes in patient with TPP and insulin has 
been shown to stimulate Na/K-ATPase activity. Hence,insulin can play a 
permissive role for the potassium shift in patients with TPP. The 
hyperinsulinemic response may explain the association of TPP with 
carbohydrate-rich meals and sweet snacks. Exercise releases potassium from 
the skeletal muscles, whereas rest promotes influx of potassium. This explains 
why paralytic attacks occur only during recovery from exercise and 
resumption of exercise can abort an attack . 
 
 Only a few patients who have  thyrotoxicosis develop TPP and not all.  
Hence this raise the possibility of genetically associated predisposition of 
Na/K-ATPase activity either directly by the thyroid hormone or indirectly via 
increased adrenergic response. The human leukocyte antigen (HLA) B46, 
DR9, and DQB1*0303 have been reported to be present at a higher prevalence 
among Hong Kong and Chinese TPP patients, whereas HLA A2, BW22, 
AW19, B17, and DRW8 are reported to be associated in Singapore, Chinese 
and Japanese, respectively 
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Differential diagnosis of hypokalemic paralysis: 
Type of potassium imbalance could be due to transcellular shift or potassium 
loss.  
Transcellular shift : 
IV insulin, Thyrotoxic periodic paralysis, Familial periodic paralysis, Sporadic 
periodic paralysis. 
 
Potassium loss: 
Renal loss of potassium- Bartter's syndrome, Gitelman's syndrome, Renal 
tubular acidosis. 
Gastrointestinal loss of potassium- diarrhoea, vomiting 
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 Where the potassium loss is obvious due to GI causes like vomiting, 
diarsrhoea, it is difficult identify renal causes  unless properly investigated. 
The urine potassium–creatinine ratio and transtubular potassium gradient 
(TTKG) are useful indices to diagnose hypokalemia secondary to renal loss. 
The TTKG is a semiquantitative index of the activity of the potassium 
secretory process, calculated by [urine K ÷ (urine osmolality/plasma 
osmolality)] ÷ plasma K. 
 
 It is very important in understanding the pathogenesis when treating.  
When the hypokalemia is due to pottasium loss it is ideal to correct potassium 
loss according to the deficit. But in managing hypokalemia were the pottasium 
loss is apparent than real as in TTP  there is danger of rebound hyperkalemia 
when the trans cellular shift reverses
47
. 
Management  
 Management can be divided into immediate correction of hypokalemia 
and treatment of the underlying disorder. 
 
Correction of Hypokalemia: 
 The hypokalemia in TPP is due to the shift if potassium from extra 
cellular compartment into the intra cellular compartment due to the over action 
of Na/K ATPase pump. It is an apparent hypokalemia and not due the real loss 
of potassium from the body.  There is a positive correlation between the dose 
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of potassium administered and the degree of rebound hyperkalemia during 
treatment.  Potassium can be given intravenously or orally to hasten muscle 
recovery and prevent cardio vascular complications.  Rebound hyperkalemia 
occurred in 40% of patients who received >90 mEq of potassium chloride 
within the first 24hours
35. Patients receiving a total dose of ≤50 mEq of 
potassium chloride rarely develop rebound hyperkalemia. Lower doses of 
potassium chloride may be effective while lowering the patient‟s risk of 
hyperkalemia. 
 
 A non selective beta-blocker (propranolol) normalizes the serum 
potassium level within hours.  Hence in addition to treatment with potassium 
the initial treatment should also include propranolol
49-52
.The mechanism of 
action of propranolol is by blunting the hyper adrenergic stimulation of Na/K 
ATPase  thus  preventing the intra cellular shift of potassium
48
.  
 
Treatment of the underlying disorder: 
 The primary therapy for TPP is the treatment for hyperthyroidism.  To 
prevent the recurrence of TPP patients should avoid the precipitating factors 
and continue propranolol till euthyroid state is reached
53
.  TPP is curable when 
the thyroid hormone normalizes with treatment.   
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Tremor in Hyperthyroidism  
 Tremor occurs in most patients of thyrotoxicosis. Reflex oscillation 
elicited by afferent muscle spindles pathway is responsible for tremor in 
hyperthyroidism rather than involvement of central oscillator like inferior 
olive, basal ganglia and thalamus. This mechanism is probably by 
enhancement of physiological tremor associated with enhanced sympathetic 
activity due over activity of thyroid hormones. The tremor disappears with 
treatment of hypothyroidism.  
 
Hyperthyroidism-associated chorea 
 Hyperthyroid disorder can occasionally give rise to chorea
55
.  Most 
often chorea occurs bilateral but sometimes occurs unilaterally. The pathology 
is often related to increased response of striatal dopamine receptors to 
dopamine suggesting the possibility of hyperthyroid status induced increased 
sensitivity of dopamine receptors
56
.  This is one of the examples of increase 
receptor site sensitivity in brain without a structure lesion. Chorea disappears 
with treatment when the thyroid function returns to normal level.  This also 
suggest the possibility of specific effects of thyroid hormone on the neuro 
transmitter system. 
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MATERIALS AND METHODS 
 
 With the aim of studying the neurological manifestations in patients 
with thyroid disorders this study was done in Madras Medical College & Rajiv 
Gandhi Government General hospital over a period of 15 months between 
December 2012 to February 2014. 
 
Methodology  
 To examine the patient attending endocrine op with thyroid dysfunction 
and who had neurological complaints and subject the patient for further 
investigations like blood testing, imaging, electroencephalogram and nerve 
conduction studies according to patients symptoms. 
 Patient attending neurology op and patient admitted in neurology ward 
were tested with thyroid function test if hyper/hypothyroidism suspected. 
Blood investigations 
 Routine blood test include complete blood count, Renal function test, 
serum electrolytes, Liver function test, lipid profile, Elisa test for HIV and 
VDRL. 
Thyroid function test 
Blood test to asses thyroid function include Thyroid-stimulating hormone 
(TSH), Free and Total Thyroxine (T4 ), Free and Total  Triiodothyronine (T3), 
Thyroid peroxidase antibody (TPO), TSH receptor antibodies (TRAb) and 
Thyroid stimulating antibodies (TSI/TSIAb) 
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Imaging of brain with CT/MRI 
 For those patients who have seizures, cognitive decline and other central 
nervous system manifestation 
 
Electroencephalogram 
 For patients with seizures 
 
Nerve conduction studies 
 For those patients with entrapment syndrome, peripheral neuropathy and 
other peripheral nervous system manifestation 
 
Electromyography 
 For those with suspected myopathy  
 
Exclusion criteria  
 Chronic illness like diabetes mellitus, chronic renal failure, liver disease, 
malignancy, HIV infection are excluded from the study. 
 
 Specific other diseases which could also accounted for the neurological 
manifestation are excluded like 
 Excluding CNS infection in suspected Hashimoto‟s encephalopathy. 
 Excluding CNS lesions by imaging in seizure disorder. 
 Excluding diabetes/chronic alcoholism in peripheral neuropathy. 
 Excluding  hereditary, inflammatory and other causes in myopathy. 
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RESULTS AND OBSERVATIONS 
   In this study 100 patients with thyroid disorders were analysed for 
neurological manifestations, in  which 50 patients were hypothyroid and 50 
patients were hyperthyroid 
 
 
Descriptive Statistics 
 
 N Minimum Maximum Mean 
Std. 
Deviation 
Age in years 100 14 72 34.62 9.927 
 
Age Group in years
Above 6051-6041-5031-4021-30Below 20
C
o
u
n
t
30
20
10
0
Group
Hypothyroidism
Hyperthyroidism
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Sex distribution of Hypo and Hyperthyroidism 
 
Sex * Group Crosstabulation 
 
 
 
 
 
Group 
Total Hypo-
thyroidism 
Hyper-
thyroidism 
Sex 
Male 
Count 4 8 12 
% within Sex 33.3% 66.7% 100.0% 
% within Group 8.0% 16.0% 12.0% 
Female 
Count 46 42 88 
% within Sex 52.3% 47.7% 100.0% 
% within Group 92.0% 84.0% 88.0% 
Total 
Count 50 50 100 
% within Sex 50.0% 50.0% 100.0% 
% within Group 100.0% 100.0% 100.0% 
Sex
FemaleMale
C
o
u
n
t
50
40
30
20
10
0
Group
Hypothyroidism
Hyperthyroidism
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 The patients with elevated TSH and low levels of thyroxine are grouped 
under overt hypothyroidism. Patients with elevated TSH alone with normal 
levels of thyroxine are grouped under subclinical hypothyroidism. 
 
 
 
 
 
74%
26%
Prevalence of Overt hypothyroidsm and 
Subclinical Hypothyroidism
Overt Hypothyroidism Sub clinical Hypothyroidism
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 In hypothyroidism 12% of patients had headache which is of tension 
type headache and it was episodic in nature. Hence we compared with other 
studies which estimated the prevalence of headache in the general population 
to know  whether the association between hypothyroidism and headache  is 
significant or not
57
. 
 
 
 
 
88%
12%
Prevalence of Tension type Headache in 
Hypothyroidism 
Normal
ETTH
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     Patients with sleep disorders in hypothyroidism is 8%.  Most of  the 
patients had complaints of increased sleepiness despite adequate night time 
sleep.  Only one patient had insomnia in the form of difficulty in initiating 
sleep.  
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Hypothyroidism
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      It is well known that hypothyroidism during infancy causes severe 
cognitive impairment. Adult onset hypothyroidism also causes cognitive 
impairment, but of lesser severity. Here 8% adult hypothyroid patients  had 
cognitive decline. Of  these  patients,  4% had Hashimoto‟s associated 
encephalopathy mediated cognitive decline which is a part of autoimmune 
encephalitis. Hence the patient having decrease in cognitive function which is 
directly due to under action of thyroid hormone is 4%.  
 
 
 
 
 
92%
8%
Prevalence of Cognitive decline in 
Hypothyroidism
Normal Cognitive decline
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 Hashimoto‟s encephalopathy is diagnosed after exclusion of other 
causes which could account for the same symptoms and signs and high titers 
of TPO antibodies.  Here we like to highlight the immune mediated 
mechanism operating causing encephalopathy in both cases, but the same 
mechanism causing myelopathy in one patient and cerebellar involvement in 
another patient. 
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Prevalence of Hashimoto's 
Encephalopathy
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 10% of the population in the study group have peripheral neuropathy. It 
was also observed patients in overt hypothyroidism are  more affected than in  
subclinical hypothyroidism. Only one patient in subclinical hypothyroidism 
had peripheral neuropathy. This patient was diagnosed as Hashimoto‟s 
encephalitis and hence the possibility of  immune mediated mechanism 
causing peripheral neuropathy  considered.  
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 The prevalence of carpal Tunnel syndrome  in  hypothyroidism is 10%.  
On comparing the prevalence of CTS in overt and subclinical hypothyroidism 
it is more associated with overt hypothyroidism. 
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 Only 2% of hypothyroid patients had myopathy and the weakness was 
mild as assessed by MRC grading is ≥4.    
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 After excluding less serious and other illness like headache where the 
association is mere a coincidence, the number of population with core 
neurological manifestations in our study is 36%.   
 
  
64%
36%
Overall Prevalence of Neurological 
manifestations in patients with Hypothyroidism 
excluding Headache 
Normal Core Neurological manifestations
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 16% of patients with hyperthyroidism had headache. Of these, 12% had 
episodic tension type headache(ETTH), 2% had chronic tension type 
headache(CTTH) and 2% had migraine. The prevalence of tension type 
headache and migraine it is no more greater than in general population when 
compared to previous studies
57
. 
  
84%
12%
2% 2%
Prevalence of Headache in Hyperthyroidism 
Normal
ETTH
CTTH
Migraine
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 Patient with sleep disorders in hyperthyroidism is 8%. All the patients 
had complaints of decrease in duration of sleep and difficulty in initiating 
sleep. 
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 Most patient in hyperthyroidism presents with tremulousness of hands. 
In our study 74% of patients had tremor initially, which disappears with 
treatment as thyroxine level normalizes. 
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 These patients presented with burning sensation over both feet with mild 
objective sensory loss over toes. The electrophysiology studies were normal 
for these patients. Hence the possibility of small fiber neuropathy was 
considered in these patients. 
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 4% of patients had proximal muscle weakness associated with 
hyperthyroidism.  One patient had generalized severe wasting in both upper 
and lower limbs associated with severe weakness.  However CK value in these 
patients was normal. Electromyography in one of the patients was suggestive 
of myopathic weakness.  
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 Only one male patient was diagnosed to have thyrotoxic periodic 
paralysis, even though there were  lesser number of male hyperthyroid patients 
in our study group. 
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 After excluding less serious form of the illness like tremor which is 
present in most hyperthyroid patients and other illness like headache where the 
association is mere a coincidence, the number of population having core 
neurological manifestations  in our study is 18%   
 
 
 
 
 
 
82%
18%
Overall Prevalence of Neurological 
manifestations in patients with Hyperthyroidism 
excluding headache and tremor
Normal Core Neurological symptoms
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Comparing the prevalence of core neurological manifestation of  
Hypothyroidism and Hyperthyroidism 
 
Core Neurological 
Manifestation 
Group 
Total 
 
P value Hypothy
roidism 
Hyperthy
roidism 
Yes 
 
 
Count 18 9 27 
 
 
0.043* 
% within Core 
Neurological 
Manifestation 
66.7% 33.3% 100.0% 
% within Group 36.0% 18.0% 27.0% 
No 
 
 
Count 32 41 73 
% within Core 
Neurological 
Manifestation 
43.8% 56.2% 100.0% 
% within Group 64.0% 82.0% 73.0% 
Total 
Count 50 50 100 
% within Core 
Neurological 
Manifestation 
50.0% 50.0% 100.0% 
 
% within Group 100.0% 100.0% 100.0% 
 
Note: * denotes significant at 5% level  
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  The prevalence of core neurological manifestations in hypo and 
hyperthyroidism were compared in this study. The association of  neurological 
manifestations more in hypothyroidism when compared to hyperthyroidism 
and is statistically significant at 5% confidence level. 
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 Peripheral neuropathy is more common in hypothyroidism and 
myopathy is more common in hyperthyroid patients. 
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DISCUSSION 
 
Neurological manifestations of hypothyroidism 
Prevalence of overt and subclinical hypothyroidism  
 In our study group of 50 patients of hypothyroidism, most of  patients 
74% had overt hypothyroidism and 26% had sub clinical hypothyroidism. 
Those patients with elevated TSH and low levels of thyroxine are grouped 
under overt hypothyroidism and those with elevated TSH alone with normal 
levels of thyroxine are grouped under subclinical hypothyroidism. 
 
Association of headache with hypothyroidism 
 On analyzing headache associated with thyroid dysfunction only 10% of 
patients had  headache. The type of headache is episodic tension type 
headache. Globally, the percentages of the adult population with an active 
headache disorder are 46% for headache in general,   42% for tension-type 
headache, 11% for migraine  and 3% for chronic daily headache
58
. In a  large, 
population-based study of epidemiology of Tension-type Headache, the 1-year 
period prevalence were 38.3% for ETTH and 2.2% for CTTH
57
.  
 
  The  prevalence of tension type headache it is no greater than in the  
general population when compared to previous studies. The prevalence  of 
headache is comparable to the general population and hence the association of 
headache cannot be attributed to hypothyroidism.  
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 Prevalence of sleep disorders in hypothyroidism 
 8% of patients with hypothyroidism had sleep related problems. Most 
had increase in the duration of sleep. They feel sleepy and tired even though 
they had adequate sleep during night. One  patient had sleep apnea causing 
poor sleep pattern in night time causing lethargy and somnolence during day 
time. Only one patient had insomnia. 
 
Cognitive decline 
 8% of patients had minimal cognitive impairment on cognitive function 
assessment. Of these, in 4% of patient it is associated with encephalopathy 
features. Only the other 4% of cases had cognitive decline only. They have 
difficulty in learning and memory. They had impairment in higher cortical 
function, especially for executive function testing and recent memory 
impairment. These patients had long standing symptoms before starting 
treatment. Their symptoms showed only moderate improvement after 
thyroxine replacement. As said in the the review of literature the therapeutic 
window in reversing the central nervous system  dysfunction is to initiate 
thyroxine supplementation with 5 to 7 months after the onset of symptoms. 
However frank dementia not occurred in our study population.   
 
Hashimoto’s  Encephalopathy  
 Two of the patient in our study had  encephalopathy associated with 
elevation of anti TPO antibodies. These patients had cognitive decline . One 
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patient had associated myeloneuropathy  and the other had cerebellar 
involvement. Both patients showed improvement following treatment with 
injection methylprednisolone 1gm IV od for 5 days followed oral steroids. 
Hence the immune mediated mechanism affecting cerebrum and spinal cord in 
one patient and cerebrum and cerebellum in other patient can be considered. 
 
Cerebellar involvement in a patient with hypothyroidism 
 There are two separate mechanisms resulting in cerebellar dysfunction 
in patients with thyroid disorders. One due to decrease in level and thus 
function of thyroxine itself and the other is immune mediated mechanism 
occurs irrespective of thyroid hormone  levels . 
 In our patient it is associated with Hashimoto‟s encephalopathy. Hence 
immune mediated mechanism is the likely possibility. This patient symptoms 
improved slowly in a period of 3 months after treatment with IV methyl 
prednisolone 1 gram od followed by oral prednisolone . She  also recieved 
thyroxine supplementation because of associated hypothyroidism.  
Myelopathy associated with Hashimoto’s encephalopathy - one of the 
rarest  association
59,60
 
 39 year old female presented with cognitive decline, apathy, pyramidal 
involvement  with brisk reflexes, extensor plantar and  MRC power grading of 
4 to 4+ in all four limbs. She also had symptoms and signs  posterior column 
involvement and peripheral neuropathy.  Etiological work up for other causes 
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were negative except for high anti TPO antibody titers and moderate elevation 
of  TSH level with normal T3,T4 levels. Imaging shows non confluent 
periventricular T2 hyperintensities without any signal intensity changes in the 
cord. Hence the diagnosis of Hashimoto‟s encephalopathy with 
myeloneuropathy was made and was treated with injection methylprednisolone 
1gram IV od for 5 days followed by oral prednisolone. Patient encephalopathy 
and myelopathy improved but peripheral neuropathy symptoms persisted. 
 
 The possible association of immune mediated mechanism for 
encephalopathy and  myelopathy can be considered since these symptoms 
improved following immunosuppressive therapy with steroids. There is no 
improvement in peripheral neuropathy symptoms and hence long standing 
hypothyroid induced peripheral neuropathy can be considered.  
 
Neuropathy 
Entrapment neuropathy 
 10% of patients had sensory symptoms confined to upper limb. These 
patients nerve conduction study suggestive of carpal tunnel syndrome. There 
was no patients with symptoms of Tarsel Tunnel syndrome.  
Peripheral neuropathy  
 10% of patient in our study had peripheral neuropathy. Of these 6% of  
patients had distal motor sensory neuropathy. Nerve conduction study of these 
patient showed axonal changes of both sensory and motor nerves 
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predominantly in lower limbs. In other 4% of patients had sensory symptoms 
confined to lower limbs only. Nerve conduction studies of these patients were 
normal. This probably attributes to small fiber neuropathy.  It was also 
observed patients in overt hypothyroidism is more affected than in  subclinical 
hypothyroidism. 
 Myopathy 
 Only 2% percent of patients in our study had complaints of proximal 
muscle weakness. MRC power grading shows only 4 to 4+ power in proximal 
muscles and distal muscle power were normal. There was no hypertrophy, 
wasting or fasiculations noted. Deep tendon reflexes showed delay in 
relaxation phase. Sensory symptoms examination  were normal. Nerve 
conductions studies  was normal. The CPK levels showed borderline elevation 
of  317U/L. This  patient refuse to undergo EMG test. 
 
Neurological manifestations of Hyperthyroidism 
Association of headache with hyperthyroidism 
 On analyzing headache associated with hyperthyroidism  only 16% of 
patients had  headache. The type of headache is tension type headache and 
migraine. The prevalence of tension type headache it is no more greater than in 
general population when compared to previous studies
57
. The  prevalence of 
headache is comparable to general population and hence the association of 
headache cannot be attributed to hyperthyroidism. 
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Prevalence of sleep disorders in hyperthyroidism 
 Patient with sleep disorders in hyperthyroidism is 8%.  Almost all 
patients had insomnia in the form of unable to initiate sleep, unable to sustain 
sleep  and getting up very early in the morning. This is probably related to the 
hyper metabolic state and anxiousness. This is associated with poor 
performance of day to day routine activities.     
 
Incidence of tremor in patient with hyperthyroidism 
 Most patient with hyperthyroidism presents with tremulousness of 
hands. The tremor is more during posture and also in action. Because of this 
they have difficulty in carrying out skilled movements with hands. In our 
study, 74% of patients had tremor initially, which disappears with treatment as 
thyroxine level normalizes. 
 
Myopathy 
Only 4% percent of patients in our study has complaints of proximal muscle 
weakness. MRC power grading shows only 4- to 4 power in proximal muscles 
and distal muscle power were normal. There was no wasting or fasiculations 
noted. One patient showed brisk deep tendon reflex. Sensory system  
examination was normal. Nerve conductions studies and CPK levels were 
normal. Needle  EMG examination features were suggestive of myopathy.  
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Peripheral neuropathy  
 4% of patient in our study had peripheral neuropathy. These  patients 
presented with burning sensation over both foot and the sensory symptoms 
confined to lower limbs only. There is mild objective sensory loss of pain and 
temperature over the toes. Nerve conduction studies of these patients were 
normal. This probably attribute to small fiber neuropathy. There were no other 
co-morbid illness which could account for the same.  
 
 Thyrotoxic periodic paralysis 
 A male patient of age 22years presented as an emergency with acute 
onset weakness involving all four limbs. He had a past history of similar 
illness 1 year ago admitted and treated in another hospital. His investigation 
showed normal nerve conduction and hypokalemia. He was treated with IV 
potassium followed by oral syrup KCl. Further investigations showed 
thyrotoxicosis. Hence he was treated with antithyroid drugs and propranalol.  
Patient now on follow up for 1year without any recurrences. 
 
               In general the incidence of thyrotoxicosis in gender male:female ratio 
is 17:1 to 70:1. TPP was observed in a  male patient with hyperthyroidism in 
our study. No females are affected by this disorder. Hence it is ideal to screen 
patients with thyroid function test presenting with hypokalemic periodic 
paralysis and at the most in males because of the more common association.   
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Comparing the neurological manifestation in hypo and hyperthyroidism 
Overall neurological manifestation in hypo and hyperthyroidism 
 On comparing only the core neurological features  associated with hypo 
and hyperthyroidism, the association is significantly high in hypothyroidism. 
This emphasis the need for assessing neurological manifestations in both 
groups but more importantly in hypothyroidism.  
 
 
Comparing the association of  peripheral neuropathy in hypo and 
hyperthyroidism 
 10% of patient in our study had peripheral neuropathy. Of these 6% of  
patients had distal motor sensory neuropathy. Nerve conduction study of these 
patient showed axonal changes of both sensory and motor nerves 
predominantly in lower limbs. Remaining 4% had small fiber neuropathy.   
 
 In contrast to this only 4% of patients with hyperthyroidism had 
symptoms confined to lower limb which is burning in nature. The nerve 
conduction study was normal in this patients. Hence the possibility of small 
fiber neuropathy is considered in this patient. Hence comparing the prevalence 
and severity of neuropathy it is less in hyperthyroidism when compared to 
hypothyroidism.  
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Comparing the association of  myopathy in hypo and hyperthyroidism 
 4% patient in hyperthyroidism had myopathy in comparison only 2% 
had myopathy in hypothyroidism. There was significant wasting and more 
severe weakness in hyperthyroid patients. The serum CK is normal in both 
hyperthyroid patients where as it is elevated in hypothyroid patient. Hence it is 
well understood there is more chance of developing myopathy in 
hyperthyroidism and in affected patients it is more severe when compared to 
hypothyroidism 
. 
Neurological manifestations confined only to hypo and hyperthyroidism 
 Even though both hypo and hyperthyroidism had features in common 
there are specific symptoms which occurs only in one group. Carpal tunnel 
syndrome and cognitive decline were confined only to hypothyroidism. 
Tremor and TPP were confined only in hyperthyroidism. Hence when 
examining either hypo or hyperthyroidism it is ideal to look for specific 
neurological manifestations.   
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CONCLUSION 
Neurological Manifestations in Hypothyroidism 
          The neurological manifestations  observed in hypothyroidism were 
headache 12%, Sleep disorders 8%, cognitive decline 4%, Hashimoto‟s 
encephalopathy 4%, cerebellar involvement 2%, myeloneuropathy 2%, carpal 
tunnel syndrome 10%, peripheral neuropathy 10% and myopathy 2% . 
      It is observed from this study that hypothyroidism can affect almost the 
entire neuro axis like cerebrum, cerebellum, spinal cord, peripheral nerves and 
muscle . Hence it is essential to screen for  thyroid function in patients with 
neurological manifestations. 
        Even though there are classical symptoms and signs associated with 
hypothyroidism, patient may present initially  with neurological symptoms 
only.  In this study, some of the patients with encephalopathy, peripheral 
neuropathy and myopathy presented without obvious symptoms of thyroid 
disorder.  
        It is important to consider immunological tests for thyroid, because 
treatment option may vary if it is abnormal.   In our study two patients had 
encephalopathy, one with overt hypothyroidism and one with subclinical 
hypothyroidism (borderline elevation of TSH only). Immunological tests 
showed gross elevation of  thyroid peroxidase antibody (TPO).  Patients 
symptoms improved after being treated with steroids and  thyroxine  
supplementation.    
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             It is most essential to diagnose and start the treatment earlier for a 
better clinical outcome.  In adult, hypothyroidism causes mild to moderate 
cognitive impairment which causes impairment of executive functions, 
learning abilities and memory  that can be diagnosed only by doing higher 
mental system examination.   In this study 4% of patients had cognitive decline 
associated with hypothyroidism and they were symptomatic for longer 
duration before the diagnosis of   hypothyroidism was arrived. Since the 
treatment with thyroxine supplementation was delayed, they had residual 
cognitive impairment even after achieving euthyroid status. 
          There are certain neurological manifestations that are specific for 
hypothyroidism. In our study cognitive decline and carpal tunnel syndrome 
occurs exclusively in hypothyroidism.  Hence it is essential to look  for these 
neurological manifestations when examining hypothyroid patients. 
Neurological Manifestations in Hyperthyroidism 
          The neurological manifestations  observed in hyperthyroidism were 
tremor 74%, headache 16%, Sleep disorders 8%,  peripheral neuropathy 4%, 
myopathy 4% and thyrotoxic periodic paralysis 2% . 
       Patient may present as an emergency masking the underlying hyperthyroid 
dysfunction and it is essential to screen for thyroid dysfunction because 
treatment options may vary depending upon the cause. In this study, one 
patient presented with second attack of hypokalemic periodic paralysis and on 
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work up found to have thyrotoxicosis. Hence diagnosed as thyrotoxic periodic 
paralysis and started on anti thyroid drugs. His hormone levels normalized and 
now on follow up without recurrence of periodic paralysis. 
          There are certain neurological manifestations that are more common  for 
hyperthyroidism. Tremor is seen in most patient 74% with hyperthyroidism 
during the initial presentations which disappears with treatment once the 
thyroid hormone level normalizes. 
          There are certain neurological manifestations that are specific for 
hyperthyroidism.  In our study tremor and thyrotoxic periodic paralysis  
occurred exclusively in hyperthyroidism.   
Comparing the Neurological Manifestations in Hypo and 
Hyperthyroidism 
            Headache occurred in 12% of patients with hypothyroidism and 16% of 
patients with hyperthyroidism. The prevalence of  headache it is no more 
greater than in general population when compared to previous studies. The 
occurrence of headache is comparable to general population and hence the 
association of headache cannot be attributed to hypo and hyperthyroidism.  
           Peripheral neuropathy occured in 10% of patients with hypothyroidism 
of which electrophysiology was suggestive of axonal changes in 6% of 
patients. In contrast only 4% of patients in hyperthyroidism had peripheral 
neuropathy which was suggestive of small fiber neuropathy where the nerve 
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conduction study was normal. Hence comparing the prevalence and severity of 
neuropathy it is less in hyperthyroidism when compared to hypothyroidism.  
              Myopathy occurred in 4% patient in hyperthyroidism  in comparison 
only 2%  in hypothyroidism. There was significant wasting and more severe 
weakness in hyperthyroid patients. Hyperthyroid patients has more chance of 
developing myopathy when compared to hypothyroid patients.  
                The serum CK is normal in both hyperthyroid patients where as it is 
elevated in hypothyroid patients. The serum CK is typically normal in 
hyperthyroidism where as it is elevated in hypothyroidism. Hence screening 
with serum CK does not rules out hyperthyroid myopathy. 
                   On comparing only the  core  neurological features associated with 
hypo and hyperthyroidism, the association is significantly high in 
hypothyroidism. 
                 Thyroid disorders can affect the entire neuro axis and may present 
with neurological manifestations without specific symptoms and signs of 
thyroid dysfunction. This emphasis the need for thyroid function testing in 
patients presenting with neurological symptoms even without classical thyroid  
symptoms. 
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PROFORMA 
Neurological manifestations in thyroid disorders  
Name-                                                    Age/Sex-                       OP/IP  No-  
                                                                                                       Phone No-     
TSH                -                                        Diffuse/nodular goiter- 
Total/FreeT3 -                                       USG- 
Total/FreeT4 -                                       TPO antibody- 
Other illness- 
 
Diagnosis-                                                      Duration of illness- 
Complaints-                                                      Treatment-     
Specific symptoms-                                                                        
 
Neurological manifestations 
Symptoms Signs 
Headache 
Anxiety 
Insomnia 
Sleepiness 
Depression 
Delirium 
Psychosis 
Disorientation 
Seizures 
CN involvement 
Weakness 
Sensory 
Ataxia 
Tremor  
HMF- 
 
CN- 
 
Motor- 
 
Sensory- 
 
Cerebellum- 
 
EPS- 
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NCS 
Motor latency amlitude CV F-wave 
R-median     
L-median     
R-ulnar     
L-ulnar     
R-peroneal     
L-peroneal     
R-tibial     
L-tibial     
 
Sensory latency amlitude CV 
R-median    
L-median    
R-ulnar    
L-ulnar    
R-sural    
L-sural    
 
Other investigations: 
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Information sheet 
 
 We are conducting a study of the “Neurological manifestions in 
patients with thyroid disorders ” at the Institute of Neurology, Rajiv 
Gandhi Govt. General Hospital, Chennai. The purpose of this study is to 
analyse the use of antiepileptic drug combinations in patients with 
epilepsy and its rationality with regard to seizure type, seizure control, 
drug interactions and adverse effects. 
 
 The privacy of the patients in the research will be maintained 
throughout the study. In the event of any publication or presentation 
resulting from the research, no personally identifiable information will 
be shared. 
 
 Taking part in this study is voluntary. You are free to decide whether to 
participate in this study or to withdraw at any time. Your decision will 
not result in any loss of benefits to which you are otherwise entitled. 
 
  The results of the study may be intimated to you at the end of the 
study period or during the study if anything is found abnormal which 
may aid in the management or treatment. 
 
 
Signature of the investigator                       Signature of the participant 
 
Date: 
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PATIENT CONSENT FORM 
Study Details : “A Study on Neurological Manifestations in   
                                                          Thyroid Disorders” 
                                                 
 
Study Centre  : Institute of Neurology, 
                                                      Madras Medical College and  
                                                      Rajiv Gandhi Government General Hospital,  
                Chennai - 600 003. 
 
Patient may check () these boxes: 
 
I confirm that I have understood the purpose of procedure for the above 
study. I have the opportunity to ask question and all my questions and doubts 
have been answered to my complete satisfaction. 
 
I understand that my participation in the study is voluntary and that I am 
free to withdraw at any time without giving reason, without my legal rights being 
affected. 
 
I understand that the investigator of the clinical study, others working on 
his behalf, the ethical committee and the regulatory authorities will not need my 
permission to look at my health records, both in respect of current study and any 
further research that may be conducted in relation to it, even if I withdraw from 
the study. However, I understand that my identity will not be revealed in any 
information released to third parties or published, unless as required under the 
law. I agree not to restrict the use of any data or results that arise from this study. 
 
I agree to take part in the above study and to comply with the instructions 
given during the study and faithfully cooperate with the study team and to 
immediately inform the study staff if I suffer from any deterioration in my health 
or well being or any unexpected or unusual symptoms. 
 
I hereby give permission to undergo complete clinical examination and 
diagnostic tests including hematological, biochemical, radiological, EMG, EEG, NCS, 
Lumbar puncture and muscle biopsy, appropriate to the clinical diagnosis. 
 
 I hereby consent to participate in this study. 
 
Signature / Thumb impression:                                                Place :                     Date : 
 
 
Patient Name and Address:              
 
Signature of Investigator:                                                            Place :                    Date : 
 
Study Investigator’s Name :         
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MASTER CHART (HYPOTHYROIDISM) 
 
S.NO NAME 
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G
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SE
X
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T4
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E 
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M
YE
LO
P
A
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Y 
1 Manonmani 50 F 148 low low 
            
yes 
    2 Sammanthiammal 56 F 29.1 low low 
            
yes 
    3 Sheela 14 F 46.2 low low 
        
yes 
        4 Thilakavathy 49 F 27.2 low low 
                 5 Savithri 39 F 34 low low 
    
yes 
      
CTS 
     6 Kanchana 38 F 16.2 low low 
   
yes 
             
7 Baby 35 F 83.65 low low yes 
                
8 Muniammal 40 F 8.5 low N 
  
yes 
     
yes 
    
yes 
   
9 Lakshmi 35 F 11.1 low low yes 
                10 Rathnakumari 24 F 6.43 N N 
                 11 Angel 37 F 13.14 N low 
                 12 Amutha 23 F 7.5 N N 
                 
13 Hamsa 27 F 7.2 N N yes 
                
14 Sasikala 19 F 5.77 low low 
                 
15 Jegadesan 35 M 17.4 low low yes 
   
yes 
            16 Sumathy 44 F 7.5 low low 
                 17 Hemavathy 24 F 25 low low 
                 18 Kamala 43 F 7 low low 
                 
19 Sumathy 32 F 60.77 low low 
           
CTS 
     
20 Rajakumari 45 F 7 N N 
           
CTS 
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21 Sivaranjani 21 F 25 low low 
            
yes 
    
22 Shanthi 30 F 6.5 N N 
    
yes 
            
23 Gilda 28 F 7.74 N N 
                 24 Sumathy 25 F 6.5 N N 
                 25 Jeyanthi 31 F 6.5 N N 
                 26 Ponkodi 44 F 100 N low 
                 
27 Suriya 39 F 11.4 N N 
  
yes 
     
yes 
   
yes 
   
yes 
28 Jamuna 44 F 7.9 low low 
                 
29 Kumari 36 F 21.5 low low 
           
CTS 
     30 Parvathy 40 F 11.5 low low 
                 31 Chinna pappa 30 F 6 low N 
       
yes 
         32 Mariammal 60 F 5.7 low N 
       
yes 
         33 Ponniammal 24 F 9.6 N N 
                 34 Girija 40 F 12.2 low low yes 
          
CTS 
     35 Saroja 72 F 7.5 N N 
                 36 Rajeswari 40 F 8.5 low low 
                 37 Stella 28 F 100 low low 
                 38 Vijaya 39 F 11 low low 
                 39 Chelladurai 28 M 19.2 low low 
        
yes 
        
40 Thangaraj 48 M 150 low low 
                 
41 Mala 36 F 88.25 low low yes 
                
42 Kattammal 60 F 15.4 N low 
            
yes 
    43 Meenakshi 21 F 8.32 N N 
                 44 Sasikala 39 F 7.5 N N 
                 
45 Sivakami 30 F 48.78 low low 
                 
46 Parimala 38 F 7.63 N N 
                 
47 Tharasundari 55 F 12.8 low low 
          
yes 
      48 Senthilnathan 37 M 14.4 low low 
                 49 Shakila 25 F 150 low low 
                 50 Sivakami 15 F 150 low low 
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